Array Biopharma Inc $3.94

down -0.07


28/8/2014 11:00 AM  |  NASDAQ : ARRY  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARRY Trend Analysis - it has underperformed the S&P 500 by 53%

Partner Headlines

  1. Earnings Scheduled For August 12, 2014

    Benzinga
  2. Pepsi Beats; Positive Phase 3 Breast Cancer Data Creates Potential Buyout ...

    Benzinga
  3. Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

    Benzinga
  4. Markets Mixed; PepsiCo Q2 Earnings Beat Street View

    Benzinga
  5. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga
  6. Array Biopharma Announces Binimetinib Continues to Advance in Clinical ...

    Benzinga
  7. Benzinga's Top #PreMarket Losers

    Benzinga
  8. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga
  9. Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ...

    Benzinga
  10. Array BioPharma Issues Update on ARRY-614 for Myelodysplastic Syndromes ...

    Benzinga
  11. Array BioPharma Issues Update on ARRY-520 for Multiple Myeloma at '13 ASHM

    Benzinga
  12. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga
  13. These ETFs House The Next Biotech Takeover Targets

    Benzinga
  14. Benzinga's Top Pre-Market Losers

    Benzinga
  15. Array BioPharma Provides Updates On Clinical Data At The 2012 American ...

    Benzinga
  16. John Orwin Joins Array BioPharma Board Of Directors

    Benzinga
  17. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus
  18. Array BioPharma CEO Favors Open, Unbiased Questions

    IBD
  19. Singles Only: 3 Low-Priced Stocks for Your Portfolio

    SchaeffersResearch
  20. Array Announces Changes to Board

    Benzinga
  21. Array BioPharma Inc. Reports Operating Results (10-K)

    GuruFocus
  22. Polypore International, True Religion Apparel Among Stocks Gapping Down ...

    FoxBusiness
  23. Health Care Sector Wrap

    FoxBusiness
  24. Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes ...

    Benzinga
  25. Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel ...

    Benzinga
  26. MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial

    Benzinga
  27. Highs & Lows: Array BioPharma, NII Holdings, and MEMC Electronic Materials

    SchaeffersResearch
  28. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,545 Shares

    GuruFocus
  29. Array BioPharma Announces Proposed Public Offering of 20M Shares

    Benzinga
  30. Benzinga's Top Pre-Market Losers

    Benzinga
  31. Array BioPharma Inc. Reports Operating Results (10-Q)

    GuruFocus
  32. Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors

    Benzinga
  33. From Earlier: Array BioPharma's Chief Executive Officer Robert E. Conway ...

    Benzinga
  34. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,994 Shares

    GuruFocus
  35. Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,743 Shares

    GuruFocus
Trading Center